Literature DB >> 14706212

Does early treatment of ocular myasthenia gravis with prednisone reduce progression to generalized disease?

Mark J Kupersmith.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 14706212     DOI： 10.1016/j.jns.2003.10.014

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN： 0022-510X            Impact factor:   3.181


× No keyword cloud information.
  5 in total

1.  Safety of prednisone for ocular myasthenia gravis.

Authors:  Beau B Bruce; Mark J Kupersmith
Journal:  J Neuroophthalmol       Date:  2012-09       Impact factor: 3.042

2.  Comparison of clinical manifestations between patients with ocular myasthenia gravis and generalized myasthenia gravis.

Authors:  Hyun Seok Roh; Sang Yeul Lee; Jin Sook Yoon
Journal:  Korean J Ophthalmol       Date:  2011-01-17

3.  Mycophenolate mofetil for ocular myasthenia.

Authors:  Jane W Chan
Journal:  J Neurol       Date:  2008-02-29       Impact factor: 4.849

4.  Clinical Utility of Acetylcholine Receptor Antibody Testing in Ocular Myasthenia Gravis.

Authors:  Crandall E Peeler; Lindsey B De Lott; Lina Nagia; Joao Lemos; Eric R Eggenberger; Wayne T Cornblath
Journal:  JAMA Neurol       Date:  2015-10       Impact factor: 18.302

5.  Juvenile myasthenia gravis: a paediatric perspective.

Authors:  Maria F Finnis; Sandeep Jayawant
Journal:  Autoimmune Dis       Date:  2011-11-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.